CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in VRDN — Viridian Therapeutics, Inc.\DE
CIK 884546
SAN FRANCISCO, CA
Position in VRDN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,238,447
-$9,069,219 QoQ
Shares Held
727,937
-2.8% QoQ
Ownership
0.706%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. VRDN ranks #78 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in VRDN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,238,447 | 727,937 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $23,307,666 | 748,961 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,847,890 | 595,361 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $8,024,813 | 574,021 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $7,629,181 | 565,963 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $11,024,091 | 575,070 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $11,743,845 | 516,213 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $6,295,812 | 483,921 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,425,728 | 424,085 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $8,087,153 | 371,311 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $4,804,748 | 313,217 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,754,572 | 115,787 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,647,540 | 104,070 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,986,430 | 102,240 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,508,489 | 73,549 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $789,606 | 68,246 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||